TCL Archive Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial April 27, 2012
TCL Archive DCPC Bard Approves Concepts For New Minority Enhancement Awards Program, Two RFA Reissues January 22, 1988
TCL Archive In Brief: ACS Seeking Candidate for Holleb Replacement; NCI To Recruit AD For Biological Carcinogenesis March 13, 1987